ERIC CAMPBELL: Open Payments
NPI 1861482887 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50,627 in 203 payments from 17 companies in 2025. Trend: 2023 $81,853 · 2024 $47,031 · 2025 $50,627
Speaker / faculty: $28,544Consulting: $8,630Travel & lodging: $7,763Food & beverage: $5,690
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 39 | $12,538 |
| Janssen Biotech, Inc. | 23 | $11,982 |
| GlaxoSmithKline, LLC. | 19 | $7,891 |
| Novartis Pharmaceuticals Corporation | 16 | $6,480 |
| UCB, Inc. | 27 | $5,786 |
| Amgen Inc. | 38 | $3,674 |
| E.R. Squibb & Sons, L.L.C. | 8 | $1,334 |
| ABBVIE INC. | 21 | $336 |
| SOBI, INC | 2 | $146 |
| KYOWA KIRIN, INC. | 1 | $135 |
Products named: SAPHNELO, TREMFYA, BENLYSTA, COSENTYX, Bimzelx, OTEZLA, KRYSTEXXA, RINVOQ.
Industry payments across OK — which companies pay providers there.
